Anticoagulation Forum

Managing Anticoagulation During the COVID-19 Pandemic


Updated Guidance Published!

Thromboembolic prevention and anticoagulant therapy during the COVID-19 pandemic: updated clinical guidance from the anticoagulation forum
May 2022 issue of the Journal of Thrombosis and Thrombolysis

AC Forum will continue to offer guidance on how best to protect your patients and staff while providing anticoagulation management during the current pandemic. Check back often for new updates!

CVS Caremark to Reverse Change to DOAC Formulary Classification


CVS Caremark has informed the American College of Cardiology that the pharmacy benefits manager will return to apixaban as a preferred product within the direct oral anticoagulants (DOACs) classification effective July 1.

Click here to view the full statement.

IDEA Initiative

The Inclusion, Diversity, Equity, and Allyship (IDEA) Initiative was established to address systemic racism and the resulting health disparities. Through this Initiative, the AC Forum will work to increase awareness and promote diversity in our leadership, membership, and programming.

Our initiatives include a webinar series, educational tools and resources, as well as scholarships to our conference and Boot Camp programs.

Learn More About Health Disparities and the IDEA Initiative.



Featured Webinar: Understanding the Social Determinants of Health
Join members of the AC Forum IDEA Initiative as they discuss how an understanding of the social determinants of health can inform how practitioners engage with patients and introduce a new AC Forum Rapid Resource on this important topic.



Could I Have Stopped a Stroke
In this quick highlight video, learn how health disparities impact a patient’s access to quality health care and anticoagulation therapy.

Rapid Resource: Social Determinants of Health & Patient Care
This resource provides a brief overview the social determinants of health and highlights actions practitioners can incorporate into their practice to address health disparities.

News & Announcements:


Anticoagulant Treatment of Cerebral Venous Thrombosis – Where are we in 2022?

Don’t miss our upcoming webinar on Monday, August 22, 2022 @ 12:00 PM ET!

Join Dr. Thalia Field, stroke neurologist, clinician-researcher, and expert in the management of cerebral venous thrombosis, along with AC Forum board members as they discuss current anticoagulant treatment of Cerebral Venous Thrombosis (CVT) and the long-term health effects in patients. The webinar will review the article “Direct Oral Anticoagulants Versus Warfarin in the Treatment of Cerebral Venous Thrombosis (ACTION-CVT): A Multicenter International Study”, which evaluated the effectiveness and safety of DOACs vs warfarin in patients with cerebral venous thrombosis.

Presenter:
Thalia Field, MD, FRCPC, MHSc

Webinar Co-Chair Panelists:
Arthur L. Allen, PharmD, CACP
Deborah Siegal, MD, MSc, FRCPC (Moderator)



We are pleased to provide 1.0 hours enduring accreditation for physicians, pharmacists, nurses, and pharmacy technicians!


ASHP Podcast: VTE Prophylaxis in the Medically Ill: Extending the Conversation, Part 3

In this podcast clip, AC Forum President Dr. Allison Burnett highlights the importance of anticoagulation stewardship, a key step in moving the needle on improving the safe and effective use of anticoagulants.

Listen to the full Podcast.  


Practitioner's Guide for Improving Oral Anticoagulant Use, Online CE from the FDA (CE), June 2020

Free 1-hour course from the FDA on all the fundamental aspects of oral anticoagulation management including overviews of disease state & risk assessment, warfarin, DOACs, DDIs and patient issues such as compliance & joint decision-making; slides and transcript available for download; 1 hour of continuing education credit is available for physicians, nurses & pharmacists until 6/1/23.

View Course Here  


FDA-funded Anticoagulation Stewardship Guide

Download our new FDA-funded release, Core Elements of the Anticoagulation Stewardship Program, which outlines systemic protocols designed  to improve the safety  and quality of care for patients and reduce the adverse drug effects related to anticoagulant medications. 

 

Literature Update

Curated & searchable literature database by topic, updated every two weeks.

View Literature Update

Upcoming Events

Follow Us On Twitter